Combination allopurinol and antimony treatment versus antimony alone and allopurinol alone in the treatment of canine leishmaniasis (96 cases)

被引:0
|
作者
Denerolle, P
Bourdoiseau, G
机构
[1] Ecole Vet Lyon, Dept Pathol & Clin Carnivores Domest, Parasitol Lab, F-69280 Marcy Etoile, France
[2] Clin Vet, Seyne Mer, France
关键词
dogs; Leishmania infantum; protozoal disease; therapy;
D O I
10.1892/0891-6640(1999)013<0413:CAAATV>2.3.CO;2
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
The aim of the present study was to evaluate the long-term clinical outcome for dogs with leishmaniasis that were treated with 3 different protocols: combined treatment with antimony and allopurinol, antimony alone, or allopurinol alone. Ninety-six dogs included in this study were determined to have leishmaniasis on the basis of (1) clinical features, (2) identification of the parasite in smears of lymph node, bone marrow aspirates, or skin biopsies, and (3) specific immunofluorescent assay. Three groups of dogs were defined: 45 dogs (group 1) were treated with antimony (100 mg/kg SC q24h) given concurrently for 1 month with allopurinol (15 mg/kg PO q12h), and then allopurinol alone for 8 months at the same dosage; 40 dogs (group 2) were treated with antimony alone according to the manufacturer's instructions (200 mg/kg SC q24h at 2-day intervals for 3-6 months); and 11 dogs (group 3) were treated with allopurinol alone (15 mg/kg PO q12h for 1-20 months). Information concerning signalment, history, physical examination findings, serologic testing and number of dogs becoming seronegative, outcome for each treated dog (clinical cure versus failure), and long-term survival were recorded. The numbers of the clinical cures versus failures were significantly different among the 3 groups (chi(2) = 17.77, P < .001), between groups 1 and 2 (chi(2) = 8.02, P < .01), between groups 2 and 3 (chi(2) = 11.00, P < .01), and between groups 1 and 3 (chi(2) = 16.52, P < .001). No significant difference between groups 1 and 2 was noted in the type of failure (relapse or death), serologic test results, and number of survival years (chi(2) = 2.79. P > .05). The results of the present study indicate that antimony in combination with allopurinol produces better results than antimony alone or allopurinol alone for the treatment of the canine leishmaniasis. With combination treatment, duration of treatment with antimony is shorter and long-term administration of allopurinol is well tolerated.
引用
收藏
页码:413 / 415
页数:3
相关论文
共 50 条
  • [41] TREATMENT OF CUTANEOUS LEISHMANIASIS WITH ANTIMONY SODIUM GLUCONATE
    KOERBER, WA
    KOEHN, MC
    JACOBS, PH
    RUSSELL, BJ
    ARCHIVES OF DERMATOLOGY, 1978, 114 (08) : 1226 - 1226
  • [42] RETENTION OF ANTIMONY IN HAIR DURING LEISHMANIASIS TREATMENT
    DOREA, JG
    MERCHANHAMANN, E
    RYAN, DE
    HOLZBECHER, J
    CLINICA CHIMICA ACTA, 1989, 179 (03) : 341 - 346
  • [43] TREATMENT OF GOUT WITH ALLOPURINOL - A STUDY OF 106 CASES
    DELBARRE, F
    AMOR, B
    AUSCHER, C
    DEGERY, A
    ANNALS OF THE RHEUMATIC DISEASES, 1966, 25 (6S) : 627 - &
  • [44] A COMPARATIVE-STUDY OF ALLOPURINOL AND PENTOSTAM IN THE TREATMENT OF VISCERAL LEISHMANIASIS
    TOBAIGY, M
    MEJER, J
    PEITERSEN, B
    ANSARI, H
    POLL, P
    PEDIATRIC RESEARCH, 1985, 19 (07) : 778 - 778
  • [45] A retrospective study of intravenous sodium stibogluconate alone and in combinations with allopurinol, rifampicin, and an immunomodulator in the treatment of Indian post-kala-azar dermal leishmaniasis
    Ramesh, V.
    Kumar, Joginder
    Kumar, Dhiraj
    Salotra, Poonam
    INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY, 2010, 76 (02): : 138 - 144
  • [46] PHARMACODYNAMIC EFFECTS AND SAFETY OF VERINURAD (RDEA3170) IN COMBINATION WITH ALLOPURINOL VERSUS ALLOPURINOL ALONE IN ADULTS WITH GOUT: A PHASE 2A, OPEN-LABEL STUDY
    Fleischmann, R.
    Winkle, P.
    Miner, J. N.
    Yan, X.
    Hicks, L.
    Valdez, S.
    Hall, J.
    Hernandez-Illas, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1364 - 1364
  • [47] Efficacy of Combined Therapy with Liposome-Encapsulated Meglumine Antimoniate and Allopurinol in Treatment of Canine Visceral Leishmaniasis
    da Silva, Sydnei M.
    Amorim, Izabela F. G.
    Ribeiro, Raul R.
    Azevedo, Erly G.
    Demicheli, Cynthia
    Melo, Maria N.
    Tafuri, Wagner L.
    Gontijo, Nelder F.
    Michalick, Marilene S. M.
    Frezard, Frederic
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (06) : 2858 - 2867
  • [48] INTRALESIONAL TREATMENT OF CUTANEOUS LEISHMANIASIS WITH SODIUM STIBOGLUCONATE ANTIMONY
    FARIS, RM
    JARALLAH, JS
    KHOJA, TA
    ALYAMANI, MJ
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 1993, 32 (08) : 610 - 612
  • [49] SUCCESSFULL TREATMENT OF AN ANTIMONY-RESISTANT CUTANEOUS LEISHMANIASIS
    KREMSNER, P
    LANG, I
    KOLLARITSCH, H
    HAUTARZT, 1987, 38 (12): : 733 - 735
  • [50] Cryotherapy with or without intralesional antimony in the treatment of cutaneous leishmaniasis
    Chaabane, H.
    Masmoudi, A.
    Dammak, A.
    Kchaou, W.
    Akrout, F.
    Zribi, M.
    Boudaya, S.
    Turki, H.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2009, 136 (03): : 278 - 279